Details

Autor(en) / Beteiligte

• Xie, Jianfei
• Wan, Ziyu
• Duan, Yinglong
• Wang, Miao
• Luo, Yating
• Xiao, Panpan
• Kang, Yue
• Zhou, Yi
• Luo, Xiaofei
• Sun, Qian
• Cheng, Andy S. K.

Titel

The efficacy of live music for adolescent and young adult patients during hematopoietic stem cell transplantation

Ist Teil von

• Supportive care in cancer, 2022-07, Vol.30 (7), p.5789-5799

Ort / Verlag

Berlin/Heidelberg: Springer Berlin Heidelberg

Erscheinungsjahr

2022

Quelle

MEDLINE

Beschreibungen/Notizen

• Background Music therapy can improve mood in patients undergoing hematopoietic stem cell transplantation (HSCT). However, live music (LM) delivered by professional music therapists is not common in developing countries owing to the shortage of professional music therapists. Thus, in this study, we explored the effects of a multidisciplinary collaborative intervention based on LM on physical and psychological well-being of adolescent and young adult (AYA) patients undergoing HSCT with a quasi-experimental design. Methods A total of 62 AYA patients agreed to participate and were randomly assigned to the intervention group receiving 4-week LM therapy ( n  = 31) or control group receiving usual care ( n  = 31). Depression, salivary cortisol, fatigue, and quality of life were the main outcome indicators measured at baseline, immediately after the intervention, 1 month, and 3 months follow-up. The intervention effects were analyzed by generalized estimating equations. Results Significant decrease in HADS-D scores occurred in the intervention group compared with wait-list controls at immediately after intervention ( p  < 0.05). Participants in the LM group had greater improvement in quality of life and lower salivary cortisol level than those in the wait-list control group at immediately, 1 month, and 3 months after intervention ( p  < 0.05). However, the interaction effects of the BFI scores were not significant. Conclusions LM therapy significantly alleviated depression and salivary cortisol levels as well as improved quality of life of AYA patients undergoing HSCT.